BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Table 9 Stage-associated transcriptional signature validation and correlation analysis (n = 159)
Parameter/variable
Spearman (ρ)
P value
VIF
ROC-AUC (95%CI)
Directional trend/validation
babA-0.467< 0.001b1.050.702 (0.632-0.795)Downregulation
iceA-0.1330.1551.000.584 (0.540-0.717)Variable
cagA0.1220.1261.050.612 (0.453-0.645)Upregulation
vacA-0.0100.2101.100.528 (0.457-0.647)Neutral
Combined model (apparent, full-cohort)ρ = 0.494< 0.001b1.020.769Linear fit
Combined model (Nested 5-fold CV)---0.747 (0.664-0.823)Calibration: Hosmer-Lemeshow χ2 = 5.53, df = 3, P > 0.05
5-fold cross-validation (Cauchit)----Accuracy: 0.535; Kappa: 0.325
CART - decision tree (apparent, full-cohort)---0.867Sensitivity: 74.5%; specificity: 81.7%
CART - decision tree (Nested 5-fold CV)---0.68 (95%CI: 0.59-0.77)Sensitivity: 54.5%; specificity: 75.0%


Write to the Help Desk